Guide

PIPE explained: private investment in public equity

Harbor Diagnostics needed $85 million in February 2026 to fund FDA trial enrollment before its next earnings call. A marketed follow-on offering would have taken six weeks and required a roadshow while the stock traded at a 40% discount to its 52-week high. Instead, management signed a PIPE — a private placement of newly issued common stock sold directly to three healthcare-focused funds at $14.10 per share, 12% below the prior close of $16.05. The deal closed in nine business days. The board deck showed 14.8% dilution from the 6.0 million new shares. What it omitted: 100% warrant coverage at $16.50 with a full-ratchet reset if the stock fell 15% within 90 days. When trial enrollment slipped and the stock hit $12.40, warrants repriced to $12.40 — adding another 4.8 million potential shares and pushing fully diluted dilution from 14.8% to 26.1%. Retail holders who read only the 8-K headline on share count missed the embedded optionality entirely.

A PIPE (private investment in public equity) is a sale of securities by a publicly traded company to accredited or institutional investors in a negotiated private transaction, rather than through a broad underwritten public offering. PIPEs trade speed and certainty of capital for a pricing discount and often warrant sweeteners. This guide explains registered direct offerings vs traditional unregistered PIPEs, pricing and discount mechanics, warrant coverage and reset clauses, resale registration and Rule 144 holding periods, SEC disclosure on Form 8-K, dilution math, the Harbor Diagnostics walkthrough, a financing decision table, pitfalls, and an investor and issuer checklist.

Why companies use PIPEs instead of follow-ons

Public companies raise equity through IPOs, follow-ons, rights offerings, ATMs, convertibles, and PIPEs. Each vehicle optimizes for different constraints: time to close, certainty of proceeds, cost of capital, disclosure burden, and signaling to the market.

When a PIPE wins

Speed — negotiated deals can close in one to three weeks vs four to eight for a marketed offering.
Distressed or thin-float stocks — when a broad roadshow would crater sentiment or fail to clear the book.
Bridge financing — capital between milestones (trial readout, acquisition close) when debt is expensive or covenants bind.
Strategic investors — funds that want a block, board observer rights, or long lock-ups in exchange for a discount.

What you give up

PIPE investors demand a discount to market — typically 5% to 15% for healthy issuers, wider when the stock is volatile or the company is burning cash. Warrant coverage (often 50% to 100% of shares purchased) and registration rights are standard. The discount signals weakness; resale registration can add selling pressure once shares become freely tradable.

Registered direct vs traditional unregistered PIPE

The label “PIPE” covers two materially different structures. Confusing them leads to wrong dilution models and surprise selling waves.

Registered direct offering (RDO)

Shares are sold under an effective shelf registration (Form S-3 for eligible issuers). Investors receive freely tradable stock at closing — no Rule 144 holding period. Disclosure is lighter than a full marketed deal but still public via prospectus supplement. Discounts tend to be narrower (often 3% to 8%) because investors bear less liquidity risk.

Traditional unregistered PIPE

The company sells restricted securities in a private placement exempt from registration (typically Rule 506(b) or 506(c) under Regulation D). Investors cannot resell until the company files a resale registration statement (Form S-1 or S-3) and it becomes effective, or until Rule 144 holding periods expire (six months for reporting companies if current on filings). Discounts are wider; warrant coverage is common compensation for illiquidity.

Read the SEC filing carefully: an 8-K announcing a “$50M PIPE” may be an RDO with immediate float expansion or a restricted deal where selling pressure arrives 60 to 120 days later when registration goes effective.

Pricing, discounts and warrant coverage

PIPE pricing is set as a fixed dollar amount or a percentage discount to a reference price — usually the volume-weighted average price (VWAP) over the five to twenty trading days before signing, or the prior close.

Typical economic package

Base shares — new common stock at the PIPE price.
Warrants — options to buy additional shares, usually at a premium to the PIPE price (e.g. 110% to 120% of PIPE price) with a five-year term.
Coverage ratio — warrants exercisable for 50%, 75%, or 100% of shares purchased in the base tranche.
Reset provisions — if the stock trades below a threshold, warrant exercise price drops (“full ratchet” or weighted-average reset). These are dilution landmines.

Fully diluted dilution math

Model three layers: (1) new shares issued at close, (2) warrants in-the-money at current price, (3) warrants that could come in-the-money under reset scenarios. Compare to market cap and cash runway — a 15% headline dilution with 100% warrant coverage and a ratchet can exceed 30% if the stock falls after close.

FD shares = basic shares + PIPE shares + warrant shares (if ITM)
Dilution % = warrant shares / (basic + PIPE shares) at various price paths

Resale registration and selling pressure

For unregistered PIPEs, the purchase agreement obligates the company to file a resale registration statement within 30 to 45 days and have it effective within 60 to 90 days. Failure triggers penalties (liquidated damages, often 1% to 2% of invested capital per month).

When registration goes effective, PIPE investors can sell into the open market. The stock often drifts down in the weeks before effectiveness as traders front-run the supply. Monitor the S-1 or S-3 resale filing for the exact share and warrant counts being registered.

Some deals include lock-up agreements where investors agree not to sell for 90 to 180 days after registration — but lock-ups can break if the stock rises 50% or on company-specific events. Treat lock-ups as soft constraints, not guarantees.

Harbor Diagnostics walkthrough

Harbor Diagnostics (fictional) traded at $16.05 with 40.5 million basic shares outstanding ($648M market cap) and nine months of cash at burn rate. Three crossover healthcare funds committed $85M for 6.0 million shares at $14.10 (12% discount) plus warrants for 6.0 million shares at $16.50 (117% of PIPE price).

What the 8-K disclosed

6.0M new shares; proceeds for Phase III enrollment and working capital.
100% warrant coverage; 90-day registration covenant.
Reset: if VWAP falls below $13.64 (15% below PIPE price) for ten days, warrant strike resets to the lower of $16.50 or market VWAP.

What happened next

Enrollment delays pushed the stock to $12.40 within six weeks. The reset triggered; warrants repriced to $12.40. At that price, all 6.0 million warrants were in-the-money. Fully diluted share count rose from 46.5M (post-PIPE basic) to 52.5M if warrants exercised — 26.1% dilution vs pre-PIPE basic, not the 14.8% the CFO quoted on the earnings call. Resale registration became effective on day 78; two funds sold 2.1 million shares over ten sessions, adding another 4% of float to supply.

The lesson: PIPE economics live in the footnotes — warrant resets, registration timing, and investor lock-up carve-outs matter as much as the headline discount.

Technique decision table

Vehicle	Best when	Tradeoff
PIPE / RDO	Fast capital, distressed price, strategic block buyers	Wide discount, warrant dilution, resale overhang
Follow-on offering	Healthy stock, time for roadshow, broad investor base	Slower; underwriting fees 3% to 7%; market signaling risk
Rights offering	Pro-rata fairness to existing holders; balance-sheet repair	Take-up risk; backstop fees; complex timeline
Convertible bond	Lower cash coupon; deferred dilution if stock rises	Refinancing risk; gamma squeeze / hedge fund dynamics
ATM program	Gradual raise at market prices on shelf	Uncertain total proceeds; persistent dribble-out supply

Issuers often pair a small RDO for immediate cash with an ATM for opportunistic taps — but stacking multiple dilutive tools in one quarter compounds signaling damage.

Common pitfalls

Headline dilution only — ignoring warrant coverage and reset clauses in fully diluted models.
RDO vs PIPE confusion — assuming a 90-day delay before selling when shares are freely tradable at close.
Discount to wrong reference — “5% discount” to a 20-day VWAP when the stock fell 25% during that window; true economic discount to spot is much wider.
Registration delay penalties — companies miss filing deadlines and pay cash penalties that further strain liquidity.
Front-running effectiveness — buying before resale registration without modeling the supply wave at effectiveness.
Strategic investor conflicts — fund holds short positions or competes in the same therapeutic area; read beneficial ownership filings after close.
Nasdaq / NYSE price rules — deep discounts can trigger exchange minimum-price or shareholder-approval requirements for issuances below market.
Stacked financings — PIPE today, convertible next quarter; cumulative dilution destroys per-share value faster than any single deal implies.

Investor and issuer checklist

Identify structure: registered direct (freely tradable) vs restricted PIPE (Rule 144 / resale S-1).
Compute dilution on basic, fully diluted, and reset-scenario warrant exercise bases.
Read warrant terms: coverage %, exercise price, term, full-ratchet vs weighted-average reset triggers.
Map registration covenant dates and liquidated damages for filing delays.
Check lock-up scope and carve-outs (price-based, event-based termination).
Compare PIPE discount to spot, 5-day VWAP, and 20-day VWAP — not just management talking points.
Review 8-K and purchase agreement exhibits for board approval thresholds and change-of-control puts.
Model cash runway post-proceeds vs burn; confirm use-of-proceeds ties to value-creating milestones.
Track resale registration filing (S-1/S-3) and expected effectiveness date for supply timing.
Compare cost of capital to follow-on, rights, convertible, and debt alternatives before signing.

Key takeaways

A PIPE trades speed and certainty for a market discount and often substantial warrant coverage — the full economic cost is rarely just the new shares at close.
Registered direct offerings deliver freely tradable stock immediately; traditional PIPEs defer selling pressure until resale registration or Rule 144 expires.
Warrant reset clauses can reprice in-the-money options after a drawdown, turning a 15% headline dilution into 25%+ on a fully diluted basis.
Harbor Diagnostics shows why investors must read 8-K exhibits, not headlines — resets and registration timing drove most of the dilution.
Compare PIPEs to follow-ons, rights offerings, and convertibles on speed, discount, and signaling before treating a PIPE as cheap capital.